Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
This Week in The Journal

This Week in The Journal

Teresa Esch [Ph.D.]
Journal of Neuroscience 11 May 2022, 42 (19) 3878; https://doi.org/10.1523/JNEUROSCI.twij.42.19.2022
Teresa Esch
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Cancer-Linked Gene Involved in Neuronal Migration

Danielle Stanton-Turcotte, Karolynn Hsu, Samantha A. Moore, Makiko Yamada, James P. Fawcett, et al.

(see pages 3931–3948)

MLLT11 is a 90 aa protein that was first identified because its gene was translocated and fused to the mixed-lineage leukemia (MLL) gene in two children with pediatric leukemia. MLLT11 has since been linked to several other cancers and has been shown to promote differentiation of hematopoietic precursors into T cells. Remarkably, the only other cell types that express MLLT11 are neurons of the PNS and CNS. The role of MLLT11 in neurons has been unknown, but Stanton-Turcotte et al. report that it contributes to migration and neurite outgrowth of cortical neurons.

Expression of MLLT11 in the developing cerebral cortex increased as upper-layer pyramidal cells were generated and were beginning to migrate through the intermediate zone and lower layers of the cortical plate. Expression increased in the upper layers as they became populated with neurons, and expression declined starting around postnatal day 21. Knocking out MLLT11 selectively in newborn upper-layer neurons led to cortical thinning, and it slowed migration of upper-layer neurons. In contrast, overexpressing MLLT11 accelerated neuronal migration into the cortical plate. Knocking out MLLT11 also reduced neurite growth: upper-layer pyramidal neurons send projections to the contralateral hemisphere through the corpus callosum, and this structure was significantly smaller in MLLT11-deficient mice than in controls. And the dendritic arbors of MLLT11-deficient upper-layer pyramidal neurons were shorter and had fewer branches than normal.

Pull-down assays revealed that MLLT11 was associated with several tubulin and myosin isoforms. Furthermore, MLLT11 colocalized with acetylated (stabilized) tubulin in cultured neurons. Notably, both neuronal migration and process extension depend strongly on microtubule dynamics. Therefore, MLLT11 may promote migration and neurite outgrowth by regulating microtubule stability. Stimulation of migration and process extension may also explain the link between MLLT11 and cancers, as these processes contribute to tissue invasion and metastasis of tumor cells.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Dendrites are longer and more highly branched in neurons cultured from control mice (top) than in neurons from MLLT11-deficient mice (bottom). See Stanton-Turcotte et al. for details.

Hippocampal Metabolites Linked to Enhancers of Cognition

Shweta Gupta, Arturo J. Moreno, Dan Wang, Julio Leon, Chen Chen, et al.

(see pages 4016–4025)

Cognitive function is influenced by numerous neuromodulators, immune-system molecules, and circulating hormones. One such hormone is α-klotho, a protein produced predominantly in the kidneys, and to a lesser extent by the choroid plexus. As a transmembrane protein, klotho acts as a coreceptor for FGF23, which regulates phosphate levels in the blood. But the extracellular domain of klotho can be shed through cleavage to produce a soluble hormone, which is carried in blood and CSF and exerts effects throughout the body. Klotho levels decline with age, and systemic administration of the soluble hormone enhances cognitive function and long-term potentiation in mice. How klotho exerts its effects in the brain is unclear, however. To address this question, Gupta et al. examined the metabolic profile of hippocampi from mice treated with either the entire extracellular domain of klotho or one of its subdomains (KL1). They compared these metabolic profiles to that of hippocampi of mice provided with cognitive stimulation—another treatment known to improve cognitive function.

Hippocampal concentrations of 154 metabolites from 42 metabolic pathways were quantified using liquid chromatography tandem mass spectrometry. Principal components analysis showed that the metabolic profiles of hippocampi of mice that had explored a Y maze were distinct from those of mice that had stayed in their home cages. Specifically, levels of 75 metabolites were higher and levels of 2 metabolites were lower in cognitively stimulated mice than in controls. Administration of klotho or KL1 also altered hippocampal metabolism, and the affected metabolites partially overlapped with those altered by cognitive stimulation. Moreover, a metabolic score based on levels of metabolites upregulated in the three conditions was correlated with performance on a spatial recognition task. Pathway analyses indicated that these shared metabolites were related to amino acid and purine metabolism.

These results suggest that cognitive stimulation and klotho treatment induce partially overlapping metabolic pathways in the hippocampus and that stimulation of these pathways is associated with enhanced recognition memory. Notably, some of the elevated metabolites, including serine, citrulline, and riboflavin, have previously been linked to synaptic plasticity and cognition. Future work will need to detail how specific metabolic pathways are activated by these treatments and how they contribute to cognitive performance.

Footnotes

  • This Week in The Journal was written by Teresa Esch, Ph.D.

Back to top

In this issue

The Journal of Neuroscience: 42 (19)
Journal of Neuroscience
Vol. 42, Issue 19
11 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
This Week in The Journal
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
This Week in The Journal
Journal of Neuroscience 11 May 2022, 42 (19) 3878; DOI: 10.1523/JNEUROSCI.twij.42.19.2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
This Week in The Journal
Journal of Neuroscience 11 May 2022, 42 (19) 3878; DOI: 10.1523/JNEUROSCI.twij.42.19.2022
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Cancer-Linked Gene Involved in Neuronal Migration
    • Hippocampal Metabolites Linked to Enhancers of Cognition
    • Footnotes
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • This Week in The Journal
  • This Week in The Journal
  • This Week in The Journal
Show more This Week in The Journal
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.